Lentigen to Move Headquarters and Manufacturing to Gaithersburg

Thursday, February 14, 2008 General News
Email Print This Page Comment
Font : A-A+

GAITHERSBURG, Md., Feb. 13 Lentigen Corporation todayannounced the company is moving its corporate headquarters and manufacturingfacilities from the University of Maryland Baltimore County TechCenter to anew 26,000 square-foot facility in Gaithersburg.

Located along Maryland's I-270 technology corridor, the expanded facilitywill accommodate Lentigen's future growth needs as a leading developer andmanufacturer of lentiviral vectors and proteins for a wide range oftherapeutic and research applications. Two self-contained suites will allowsimultaneous multi-product manufacture in compliance with FDA-regulatedcurrent good manufacturing practices and EMEA regulatory standards.

"We are very pleased to have found a facility that will meet our expansionrequirements for both research-grade and clinical-grade operations," said TimRavenscroft, Lentigen's chief executive officer. "Located in the heart ofMaryland's technology corridor, we will be well situated to attract talentedindividuals to our growing organization and to meet the increasing needs ofour partners and customers."

About Lentigen Corporation

Lentigen Corporation is a privately owned biotechnology company focused onthe development of lentiviral vector technology for a wide range oftherapeutic, vaccine and research applications in biotechnology and medicine.Lentiviral vectors are the most efficient vehicles for the delivery of genesor gene silencing sequences stably into cells. Lentigen is a highlycollaborative company, co-developing lentiviral vector-based products across abroad spectrum of bench to clinical applications. Partnerships include TheNational Institutes of Health, The University of Pennsylvania, ThermoFisherScientific and The U.S. Army. For further information, visithttp://www.lentigen.com/Contact: Gregory Tiberend gtiberend@rlcinc.com Meghan Feeks mfeeks@rlcinc.com Richard Lewis Communications, Inc. 212-827-0020

SOURCE Lentigen Corporation


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook